Unusual 11 Midday Movers 02/03: (THLD) (ZOLT) (TUDO) Higher; (STRI) (PCCC) (SMT) Lower

FREE Breaking News Alerts from StreetInsider.com!

THLD Hot Sheet

Overall Analyst Rating:
BUY (= Flat)

Threshold Pharmaceuticals, Inc (Nasdaq: THLD) 86% HIGHER; today announced that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug. TH-302 is currently being investigated in a global Phase 3 clinical trial in patients with soft tissue sarcoma, a randomized Phase 2 trial in patients with advanced pancreatic cancer from which top-line results are expected in February, as well as additional clinical studies in other solid tumors and hematological malignancies.

Zoltek Companies, Inc. (NASDAQ: ZOLT) 40.8% HIGHER; reported Q4 EPS of $0.28, which may not compare to the analyst estimate of $0.04. Revenue for the quarter came in at $47.05 million versus the consensus estimate of $43.5 million.

Tudou Holdings (Nasdaq: TUDO) 28.1% HIGHER; shares began surging after noon but volume didn't start spiking until about 12:30pm. Shares are now flirting with the $18 level. Traders may be buying the stock today as a play on the Facebook craze which has been very quiet over the last few weeks.

STR Holdings, Inc. (NYSE: STRI) 20% LOWER; has announced that revenue is projected to approximate $36.5 million for the fourth quarter of 2011 and diluted non-GAAP EPS is projected to be in the range of ($0.04) to ($0.02). Projected revenue is below the Company’s guidance of $44 to $48 million. Projected diluted non-GAAP earnings per share is below the previously-announced guidance range of $0.09 to $0.12. The Street sees Q4 revs of $43.95 million and EPS of $0.10. Prior Q4 outlook was EPS $0.09 - $0.12 and revs of $44 - $48 million.

Firsthand Technology Value Fund (Nasdaq: SVVC) 19.7% HIGHER; Recently the company said Facebook is now the fund's largest holding, representing more than five percent (5%) of the fund's net assets. Traders playing the Facebook craze, then.

PC Connection, Inc. (NASDAQ: PCCC) 19.3% LOWER; reported Q4 EPS of $0.28, $0.08 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $553.2 million versus the consensus estimate of $590.29 million.

Silicon Image, Inc. (NASDAQ: SIMG) 17.5% HIGHER; reported Q4 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $58.7 million versus the consensus estimate of $55.48 million.

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) 16.5% HIGHER; and Takeda Pharmaceuticals U.S.A., Inc. announced late yesterday lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone.

Smart Technologies, Inc. (NASDAQ: SMT) 13.5% LOWER; reported Q3 EPS of $0.09, $0.04 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $185.1 million versus the consensus estimate of $179.23 million.

Idenix (Nasdaq: IDIX) 12.4% LOWER; despite news of the removal of a partial clinical hold on HCV nucleotide inhibitor, IDX184, shares are moving lower amid strong '7977 data from Gilead (Nasdaq: GILD).

MannKind Corporation (Nasdaq: MNKD) 13% LOWER; today announced the pricing of an underwritten public offering of 31,250,000 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.6 of a share of its common stock. The shares of common stock and the warrants are being offered at a combined price to the public of $2.40 per unit. The gross proceeds to MannKind from this offering are expected to be $75.0 million.

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!